Equatorial Guinea vs Iran, Islamic Republic of: The number of people with susceptibility test result for rifampicin
Equatorial Guinea
54.36
in 2021
Iran, Islamic Republic of
46.76
in 2021
Equatorial Guinea rank
113th
Iran, Islamic Republic of rank
116th
The number of people with susceptibility test result for rifampicin over time
- Equatorial Guinea
- Iran, Islamic Republic of
How they compare
Equatorial Guinea currently reports 54.36 against 46.76 in Iran, Islamic Republic of, a difference of 7.6.
That makes Equatorial Guinea's figure about 1.2 times Iran, Islamic Republic of's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Iran, Islamic Republic of ahead.
Equatorial Guinea ranks 113th and Iran, Islamic Republic of ranks 116th of 146 countries.
Iran, Islamic Republic of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Iran, Islamic Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.02 | 64 | 59.98 | Iran, Islamic Republic of |
| 2020s | 42.43 | 45.93 | 3.5 | Iran, Islamic Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Equatorial Guinea or Iran, Islamic Republic of?
- Equatorial Guinea, at 54.36 against 46.76 in Iran, Islamic Republic of as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Equatorial Guinea and Iran, Islamic Republic of?
- 7.6, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Iran, Islamic Republic of?
- 5 years are reported by both, from 2017 to 2021.
- How do Equatorial Guinea and Iran, Islamic Republic of rank globally for the number of people with susceptibility test result for rifampicin?
- Equatorial Guinea ranks 113th and Iran, Islamic Republic of ranks 116th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.